Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,006,746
-
Share change
-
+125,815
-
Total reported value
-
$20,827,000
-
Put/Call ratio
-
14%
-
Price per share
-
$5.22
-
Number of holders
-
19
-
Value change
-
+$725,258
-
Number of buys
-
7
-
Number of sells
-
11
Institutional Holders of VASCULAR BIOGENICS LTD - COM (VBLT) as of Q3 2016
As of 30 Sep 2016,
VASCULAR BIOGENICS LTD - COM (VBLT) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,006,746 shares.
The largest 10 holders included
First Eagle Investment Management, LLC, FRANKLIN RESOURCES INC, Knoll Capital Management, LP, Migdal Insurance & Financial Holdings Ltd., MACQUARIE GROUP LTD, TURNER INVESTMENTS LLC, MENTA CAPITAL LLC, KCG Holdings, Inc., NEXTHERA CAPITAL LP, and IFP Advisors, Inc.
This page lists
19
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.